Literature DB >> 29152043

Lysine-Specific Demethylase 1 (LSD1) Inhibitors as Potential Treatment for Different Types of Cancers.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2017        PMID: 29152043      PMCID: PMC5683701          DOI: 10.1021/acsmedchemlett.7b00426

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  A Systematic Review of Histone Lysine-Specific Demethylase 1 and Its Inhibitors.

Authors:  Yi-Chao Zheng; Jinlian Ma; Zhiru Wang; Jinfeng Li; Bailing Jiang; Wenjuan Zhou; Xiaojing Shi; Xixin Wang; Wen Zhao; Hong-Min Liu
Journal:  Med Res Rev       Date:  2015-05-19       Impact factor: 12.944

Review 2.  Epigenetic regulation of epithelial to mesenchymal transition by the Lysine-specific demethylase LSD1/KDM1A.

Authors:  Susanna Ambrosio; Carmen D Saccà; Barbara Majello
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-07-15       Impact factor: 4.490

Review 3.  Inhibitors of LSD1 as a potential therapy for acute myeloid leukemia.

Authors:  Amanda Przespolewski; Eunice S Wang
Journal:  Expert Opin Investig Drugs       Date:  2016-04-21       Impact factor: 6.206

  3 in total
  1 in total

Review 1.  LSD1/KDM1A inhibitors in clinical trials: advances and prospects.

Authors:  Yuan Fang; Guochao Liao; Bin Yu
Journal:  J Hematol Oncol       Date:  2019-12-04       Impact factor: 17.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.